Antithrombin III (ATIII) is a member of the serpin superfamily and a major
regulator of the blood coagulation cascade. To express recombinant human AT
III (rATIII) in the methylotrophic yeast Pichia pastoris, we constructed an
rATIII expression plasmid which contained the ATIII cDNA encoding mature p
rotein region connected with the truncated mAOX2 promoter and the SUC2 secr
etion signal, introduced it into the P. pastoris genome, and screened for a
single copy transformant. The secretion of rATIII from the transformant re
ached a level of 320 IU/L in the culture broth at 169 h. From the culture-s
upernatant, rATIII was purified to over 99% by heparin-affinity chromatogra
phy and other column chromatography methods. We characterized rATIII and co
mpared it with human plasma-derived ATIII (pATIII). The purified rATIII pos
sessed correct N-terminal amino acid sequence, and its molecular weight by
SDS-PAGE of 56,000 Da was slightly different from the 58,000 Da of pATIII.
Sequence and mass spectrometry analysis of BrCN fragments revealed that pos
ttranslational modifications had occurred in rATIII. O-linked mannosylation
was found at Ser 3 and Thr 9, and in some rATIII molecules, modification w
ith O-linked mannosyl-mannose had probably occurred at Thr 386, close to th
e reactive center. Although the heparin-binding affinity of rATIII was 10-f
old higher than that of pATIII, its inhibitory activity against thrombin wa
s only half. As the conformation of rATIII and pATIII by circular dichroism
spectroscopy was similar, O-glycosylation in the reactive center loop was
assumed to be mainly responsible for the decreased inhibitory activity. pAT
III can inactivate thrombin through formation of a stable thrombin-ATIII co
mplex, but rATIII modified with O-glycosylation in the reactive center loop
may act as a substrate rather than an inhibitor of thrombin. (C) 2001 Acad
emic Press.